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symptoms in adult brain tumor
patients: a scoping review
Maria Kangas*
Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, NSW, Australia
Background: Adult brain tumor (BT) patients and longer-term survivors are susceptible to
experiencing emotional problems, including anxiety and/or depression disorders, which
may further compromise their quality-of-life (QOL) and general well-being. The objective
of this paper is to review psychological approaches for managing anxiety and depressive
symptoms in adult BT patients. A review of psychological interventions comprising mixed
samples of oncology patients, and which included BT patients is also evaluated. The
review concludes with an overview of a recently developed transdiagnostic psychotherapy
program, which was specifically designed to treat anxiety and/or depressive symptoms
in adult BT patients.
Methods: Electronic databases (PsycINFO, Medline, Embase, and Cochrane) were
searched to identify published studies investigating psychological interventions for man-
aging anxiety and depressive symptoms in adult BT patients. Only four randomized
controlled trials (RCTs) were identified.
Results: Only one of the RCTs tested a psychosocial intervention, which was specifically
developed for primary BT patients, and which was found to improve QOL including
existential well-being as well as reducing depressive symptoms. A second study tested
a combined cognitive rehabilitation and problem-solving intervention, although was
not found to significantly improve mood or QOL. The remaining two studies tested
multidisciplinary psychosocial interventions in heterogeneous samples of cancer patients
(included BT patients) with advanced stage disease. Maintenance of QOL was found in
both studies, although no secondary gains were found for improvements in mood.
Conclusion: There is a notable paucity of psychological interventions for adult BT
patients across the illness trajectory. Further research is required to strengthen the
evidence base for psychological interventions in managing anxiety and depressive
symptoms, and enhancing the QOL of distressed adults diagnosed with a BT.
Keywords: brain tumor, psychological treatment, anxiety, depression, emotional well-being
Introduction
Adult individuals diagnosed with a primary brain tumor (BT) represent a unique group of patients
on the basis that both benign and malignant tumors are associated with disease and treatment
Frontiers in Oncology | www.frontiersin.org May 2015 | Volume 5 | Article 1161
Kangas Psychotherapy interventions for brain tumor patients
side-effects, and can be life-threatening. Depending on the site
and size of the BT, these side-effects can lead to substantial neu-
rocognitive, psychosocial, and behavioral problems (1–3). Impor-
tantly, a growing body of studies has found that BT survivors are
prone to experiencing a high incidence of psychological problems
following their diagnosis. Prevalence rates for depression and
anxiety symptoms have been documented to be as high as 62%
(1, 4). Given the potential life-threatening nature of this disease,
several studies have further found that BT survivors may also be
susceptible to clinically elevated acute and posttraumatic stress
symptoms (PTSS) (5–7).
Research has further shown that if emotional symptoms are
left untreated, they have an unremitting, chronic course ham-
pering quality-of-life (QOL) and productivity [e.g., Ref. (8)].
Importantly, these findings accentuate the importance of provid-
ing psychological interventions for adult BT patients in order to
manage acute psychological problems, as well as prevent chronic
psychopathology and maintain QOL in longer-term survivors.
To date, no published study has evaluated the evidence base of
psychosocial interventions suitable for distressed (notably, anx-
ious and/or depressed) adult BT patients. This line of inquiry is
important in order to guide clinicians and researchers working
with this population. Accordingly, the primary objective of this
scoping review is to evaluate published psychological-based clin-
ical trials which were either: (a) specifically tailored for adults
diagnosed with a primary BT, or (b) comprised heterogeneous
oncology patients including BT patients, in order to assess the
efficacy of psychological interventions in managing anxiety and
depressive symptoms, as well as maintaining or improving the
QOL in adult BT patients including longer-term survivors. Given
the infancy of this field, this reviewwill concludewith an overview
of a recently developed transdiagnostic psychotherapy program,
which was specifically designed to treat anxiety and/or depressive
disorders in adult BT patients.
Methods
Scoping Review
Given this type of review is a relatively new methodological
approach, to date, there is no universal definition, or consensus
on a definitive methodological procedure on reporting guidelines
(9). Whereas some authors have proposed that scoping reviews
provide a “descriptive overview” of relevant material without
critically evaluating and/or synthesizing evidence across differ-
ent studies (10), more recently, other authors have indicated the
importance of synthesizing and critically evaluating the evidence
reviewed [e.g., Ref. (11, 12)]. Indeed, without critical evaluation of
the methodology of identified studies, researchers and clinicians
are unable to delineate relevant gaps in the field in order to guide
further research, clinical practice, and policy guidelines (9, 11).
To this end, although Arksey and O’Malley in 2005 (10) pub-
lished the first methodological framework for scoping reviews,
several authors have proposed revisions to this framework (11–
13). In particular, Pham and colleagues (9) recommend that
researchers utilize the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) (14) as a further guide
in reporting results for scoping reviews. Accordingly, for the
purposes of the current scoping review, Arksey and O’Malley’s
(10) six-stage iterative framework was used in combination with
relevant components of the PRISMA framework (14). However,
as the 6th step (consulting with relevant stakeholders) is proposed
to be optional in Arksey and O’Malley’s framework, this final step
was excluded for the purposes of the current review. Moreover,
in selecting the research question (i.e., Step 1 of Arskey and
O’Malley’s framework), Levac and colleagues (13) further recom-
mend to clearly define the question including target population
and health outcomes in order to clarify the specific focus of the
review. In line with these recommendations as outlined above, the
specific aims of the current scoping review explicitly focused on
evaluating psychological-based intervention studies for managing
anxiety and/or depressive symptoms and/or improving QOL in
adult BT survivors. Given this specific focus, the review outcomes
are expected to identify relevant gaps in the literature concerning
interventions for managing anxiety and depressive symptoms in
adult BT patients, in order to guide clinical practice and relevant
future research in this area.
Search Strategy
The following electronic databases were searched from their
respective inceptions through to the 10 December, 2014:
Cochrane, Embase, Ovid Medline, and PsycINFO. The searches
were conducted using the following subject headings and/or
keywords and combinations: (i) brain (or CNS) tumor/tumour,
brain neoplasm, brain cancer, neurooncology, glioma,
meningioma; and (ii) psychosocial intervention terms [including
counseling/counselling, psychotherapy, psychoeducation,
psychosocial intervention/psychosocial/psychological therapy/
treatment, stressmanagement, cognitive behavioral/(behavioural)
therapy, cognitive therapy, CBT, behaviour/behavior therapy,
relaxation]. The searches were restricted to abstracts and
articles published in English. A further search was conducted to
identify review articles based on psychosocial interventions for
oncology populations (specifically comprising heterogeneous
samples of oncology patients). The bibliographies of retrieved
articles, narrative reviews, and commentary articles on BTs
and psychosocial intervention reviews for cancer patients
(comprising heterogeneous samples) were alsomanually searched
for additional references. The abstracts of articles identified by
electronic searches (1904 in total) as well as manual searches were
screened for consideration of inclusion in this review.
Study Selection
All abstracts and/or titles of articles that were identified via elec-
tronic and manual searches were screened applying the following
selection criteria: (i) published in a peer reviewed journal in full
manuscript format; (ii) written in English language; (iii) included
a psychosocial intervention (with details of key components pro-
vided), which was compared to a standard care, wait-list control,
or other type of comparison condition, single design and/or case
studies focusing on managing psychological distress were also
considered; (iv) participants were a minimum of 18 years of age;
(v) the study sample explicitly comprised of patients diagnosed
with a primary BT, or for mixed oncology samples, a minimum
of 10% of the sample was diagnosed with a BT; and (vi) a specific
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quantitative measure of psychological well-being (including anxi-
ety and/or depression/mood and/or a QOL scale) was included as
a primary or secondary outcome measure, and the measure was
administered at minimum pre- and post-intervention.
Data Extraction and Evaluation of Clinical Trials
Studies which met inclusion criteria were read in full, and the fol-
lowing data were extracted and summarized in table format: ref-
erences, country of study, aim of study, study design, participant
characteristics (including sample size, mean age, and BT composi-
tion), intervention details, assessment phases andmeasures, study
outcomes, and limitations.
Results
A total of five published articles (15–19)met the inclusion criteria,
although only four of the studies (15–18) were included in this
review. The fifth study (19) was excluded, as it was based on the
same dataset as one of the included studies (17), and did not report
any new data. Although two further case studies were identified
(20, 21), they were excluded as both studies did not include a
measure of psychological well-being. These two excluded stud-
ies focused on testing psychological interventions for managing
challenging behaviors in BT patients (20), and managing anger
disturbances more broadly with brain injured adults including
BT patients (21). In addition, a further recent non-randomized,
controlled trial was identified (22), whichwas designed to evaluate
the effectiveness of a multidisciplinary rehabilitation (MDR) pro-
gram for adults diagnosed with a primary glioma in an Australian
community cohort. However, this studywas excluded as no details
were provided pertaining to the psychological intervention(s)
used. Notably, the authors reported that part of theMDR program
comprised 30-min blocks of therapy sessions conducted 2–3 times
per week for up to 8weeks, which included psychology, social,
occupational, and physiotherapy. However, no specific informa-
tion was provided as to what these components comprised, and
whether the psychological therapy approach was consistent across
patients.
Table 1 summarizes the sample characteristics, intervention
details, and outcomes of four randomized controlled trials (RCTs).
Only two of the four identified studies were solely based on
a primary BT sample. Specifically, based on a RCT design,
Ownsworth et al. (15) tested the efficacy of a multimodal, home-
based intervention [i.e., the “Making Sense of Brain Tumor”
(MSoBT) program], which was designed to improve QOL, exis-
tential, and mental health well-being in adults with a primary
BT. The manualized intervention was administered in individ-
ual and/or combined couple/family support sessions, over 10
weekly, 1-h sessions. At post-intervention, patients who received
the MSoBT program were found to report significantly lower
depressive symptoms, and an improvement in existential and
functional well-being relative to patients randomized to a wait-list
condition. At 6-months follow-up, the results for the two condi-
tions were combined, and the findings indicated that participants
experienced an improvement in existential well-being and overall
QOL, as well as a significant decline in depressive symptoms, but
not anxiety symptoms.
In the second study which focused solely on BT patients, Locke
et al. (16) quasi-randomly allocated a very small dyadic sample
(n= 19) of adults diagnosed with a primary BT and their car-
ers, to a combined cognitive rehabilitation and problem-solving
intervention or to the standard medical (control) condition. The
design was quasi-RCT as the final three patient-dyads recruited
were directly allocated to the intervention condition. Themajority
of participants (88%, n= 7 of 8) who received the intervention
reported using the intervention strategies for a minimum, sev-
eral times per week at the end of the 2-week trial period, while
50% continued to use these strategies several times per week at
3-months follow-up. Similarly, 88% of participants in the inter-
vention condition reported finding the program “somewhat” or
“very” helpful. However, no differences were found between the
intervention and standard care/control conditions in terms of
improvement in QOL, functional capacity, emotional distress, or
fatigue at the completion of the trial period, or at the 3-months
follow-up assessment. In particular, a high proportion of par-
ticipants (n= 16) reported average to above average scores on
the QOL measure at baseline, and at the two subsequent follow-
up assessments. Comparably, over 77% of participants mood
scores indicated good emotional adjustment at each of the three
assessments (inclusive of the baseline period). Furthermore, the
effects of the intervention on cognitive functioning could not be
tested, as themajority of patients at the follow-up assessment were
assessed via telephone, thus ruling out the administration of the
neurocognitive test.
The other two randomized controlled studies were based on
mixed samples of patients diagnosed with advanced cancer. In the
first study, Rummans et al. (17) tested the efficacy of a structured
multidisciplinary intervention in maintaining QOL in advanced
cancer patients (including 12% of patients with BTs) scheduled
to receive a minimum of 2weeks radiation treatment. The group-
based intervention comprised eight weekly, 90min sessions con-
ducted over 3weeks, and which included weekly physical and
relaxation exercises as well as cognitive-behavioral strategies and
open group discussions. The primary endpoint was 4weeks post-
baseline assessment (i.e., 1 week post-intervention), although a
27-week (5-month) follow-up assessment was also conducted.
The results revealed that at 1-week post-intervention, participants
were found tomaintain their QOL relative to patients randomized
to the standard care condition, which reported a decline in QOL
scores. However, by 5months follow-up, no significant differences
were evident between conditions. Specifically, both groups QOL
scores were comparable to baseline functioning.
In a more recent study, Clark et al. (18) adapted Rumman et al.’s
(17) program and tested the efficacy of this structured multidisci-
plinary intervention in maintaining QOL in a further sample of
advanced cancer patients (including 22% with BTs), which were
recommended to receive at least 1-week of radiation treatment.
In this study, the intervention was reduced to six sessions, which
included caregiver participation, as well as an additional 10 brief
follow-up phone counseling sessions. The primary endpoint for
this study was also at 4 weeks following the baseline assessment,
although a 5-month follow-up was also included. At the 4-week
assessment, participants in the intervention condition reported
elevated QOL scores, particularly an improvement in physical
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TABLE 1 | Study characteristics and outcomes.
Reference
and country
Participant characteristics Intervention design and details Assessment phases and
outcome measures
Results Limitations
(A) STUDIES COMPRISING SOLELY OF PRIMARY BRAIN TUMOR PATIENTS
Ownsworth
et al. (15)
Australia
 N=50 adults (54% males)
diagnosed with primary BT
assessed at baseline (min.
18yrs old; range: 17–82)
 54% with benign or low
grade BTs
 Mean=2.6 yrs since BT
diagnosis (range: 6weeks to
18 yrs)
 N=27 randomized to MSoBT
[Ns per Ax: 27, 25, 21];
dropouts due to death (n=2);
declined FU assessment
(n=3); unable to contact (n=1)
 N=23 randomized to wait-list
control [Ns per Ax: 23, 21, 15];
dropouts due to death (n=2);
declined FU assessment
(n=2); unable to contact
(n=1); withdrew from study
before intervention (n=1) or
FU assessment (n=2)
 RCT with wait-list control
 MSoBT: 10 1 hourly weekly
sessions, comprising core
components covered in sessions
1, 2, and 10, and module
components covering goals, life
situation, and cognitive capacity;
Program included family members
– MSoBT format: home based,
manualized, individual and/or
combined couple/family support
sessions
– Tx modules included
psycho-education,
neuropsychological feedback,
cognitive rehabilitation,
psychotherapy for anxiety, anger,
and depression, couple and family
support
 Wait-list control – received MSoBT
after T2 Ax
 Ax phases:
T1 – baseline
T2-Post-Tx
T3-6months FU
 Measures:
– Neuropsych battery to index global
functioning
– QOL: McGill Quality of Life
Questionnaire (MQOL) [inc.
existential subscale]
– QOL for BT: Functional Assessment
of Cancer Therapy – Brain subscale
(FACT-BR) (T1 and T2 only)
– Depression severity:
Montgomery-Asberg Depression
Rating Scale (MADRS)
– Anxiety, stress, depressive
symptoms: Depression Anxiety
Stress Scale (DASS21)
 All analyses based on N=50, as ITT analyses were
used, although only N=44 completed T3
 T1–T2 outcomes
 MSoBT: sig. lower depressive symptoms on MADRS
but not on DASS21
 MSoBT: sig. elevated existential wellbeing (MQOL)
 MSoBT: sig. greater functional well-being and total
QOL score on FACT-BR, but not for overall score on
MQOL
 T1–T3 outcomes:
 Sig. lower depressive symptoms on MADRS and
DASS21
 Sig. higher existential well-being scores and overall
QOL (MQOL)
 Sig. lower stress symptoms on DASS21, but not for
anxiety symptoms
 Secondary analyses at T3:
 Benign BTs: sig. less depressive symptoms (MADRS)
and stress (DASS21), but no sig change for
existential well-being, anxiety, or overall QOL (MQOL)
 Malignant BTs: sig. less depressive symptoms
(MADRS) and sig. increase in existential well-being
and QOL (MQOL). However, no sig. change on
DASS21 scores
 No blinding of assessors or
therapists, and no details of
therapist fidelity checks
reported
 T3/6mth FU analyses not
based on RCT as data
merged for both MSoBT and
wait-list conditions. Also
access to other services
between T2 and T3 not
monitored
Locke et al.
(16) USA
 N=19 patient-carer dyads
(58% males) diagnosed with a
primary BT scheduled to
receive radiotherapy (min.
18 yrs old; range: 30–78)
 32% with benign or low
grade BT
 53% also received
neurosurgery and 63%
received chemotherapy
 N=9 randomized to the
combined intervention plus
N=3 directly allocated to the
intervention (combined N=12)
[N=8 completed study
inclusive of 3-mth FU;
dropouts due to carer not
willing to accompany patient to
intervention and fatigue]
 N=7 randomized to the
standard medical care/control
condition [N=5 completed
3-mth FU; dropouts due to BT
progression]
 RCT (quasi-design as final 3 dyads
directly allocated to the
intervention) with a standard
medical care (control) condition
 Combined Cognitive Rehabilitation
(CR) and Problem-Solving (PS)
intervention: Each component (CR
& PS) comprised 650 min
sessions each over a 2-week
period, concurrent with
radiotherapy
 CR component based on Sohlberg
and Mateer’s techniques based on
using a specific calendar format to
compensate for cognitive
symptoms
 PS component was based on
Nezu et al.’s techniques and
focused on positive
problem-solving skills to manage
stress reactions
 Standard medical care (control)
condition – no details reported
 Ax phases:
T1 = baseline
T2 = post-Tx
T3 = 3mths FU
 Primary measures:
– Compensation Techniques
Questionnaire
– Mayo-Portland Adaptability
Inventory-4 (MPAI-4) – functional
capacity Ax
– QOL for BT: Functional Assessment
of Cancer Therapy – Brain subscale
(FACT-BR)
 Secondary measures:
– The Repeatable Battery for the
Assessment of Neuropsychological
Status (R-Bans) – test multiple areas
of cognitive functioning
– One-item Linear Analog
Self-Assessment (LASA) – assess
overall QOL
– The Caregiver QOL Index-Cancer
– Profile of Moods State
(POMS) – mood severity
– The Brief Fatigue Inventory (BFI)
 No significant between or within group differences
found on any primary or secondary measure
 Very small sample size, and
low response rate from
potential pool of N=160
patients. 38% screened
excluded as they had no
cognitive deficit, while 16%
declined the neuropsych. Ax
 Patients not recruited on
basis of baseline emotional
and general well-being,
hence results indicate
potential ceiling effects as
majority of sample were well
adjusted emotionally at
baseline
 Due to very low number
assessed in person at T3,
cognitive Ax could not be
conducted
 No details reported of what
the standard medical care
condition received and
whether access to additional
services was assessed
(Continued)
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TABLE 1 | Continued
Reference
and country
Participant characteristics Intervention design and details Assessment phases and
outcome measures
Results Limitations
(B) STUDIES COMPRISING HETEROGENEOUS SAMPLES OF ONCOLOGY PATIENTS INCLUDING BRAIN TUMOR PATIENTS
Rummans
et al. (17)
USA
 N=112 adults [N=55
intervention, N=57 standard
care] with advanced cancer,
diagnosed within last
12mths, with min. 6mth
survival, and prescribed
radiation Tx (min. 2weeks)
 Mean age=59.5 yrs (range:
31–85 yrs)
 Complete data N=103 (66
males; 12% BT patients) with
N=49 intervention (N=6
BTs; 12.2%), and N=54
standard care (N=6 BTS,
11.1%)
 RCT with standard care
 Primary Intervention:
– Structured multidisciplinary program
comprising 890 min sessions
conducted over 3weeks
– Session structure inc. 20min
physical exercises; educational
information; cognitive behavioral
strategies for coping with cancer
(inc. problem-solving, stress
management, assertiveness, relapse
prevention); open group discussion
(inc. social and spiritual topics,
interpersonal relations, grief), and
concluded with 10–20min guided
relaxation exercises
– Participants issued with workbook
 Standard care:
– Inc. regular medical consults and
opportunities for receiving support
from outside agencies, e.g., America
Cancer Society
 Ax phases:
T1 – baseline
T2-Post-Tx/4weeks later (primary
study end-point)
T3-8weeks from T1
T4–27weeks from T1
 Primary outcome measures:
– Spitzer QOL Uniscale & Linear Analog
Scales of Assessment of QOL (LASA)
 Secondary outcome measures:
– Symptom Distress Scale
– Profile of Mood States (POMS)
– Functional Assessment of Chronic
Illness Therapy (FACIT) – Spiritual
well-being scale
 N=103 in final analyses; [N=49 Intervention (n=6
withdrew due to incomplete session attendance),
N=54 Standard care (n=3 declined)]
 T1 to T2:
 Greater QOL scores for intervention condition
(intervention condition increased scores by 3
points – vs. standard care condition decreased
scores by 9 points at T2); hence intervention group
maintained QOL by T2
 T1–T4 (5mths FU):
 No sig. group differences, both conditions continued
to increase QOL scores
 Secondary measures:
 Only POMS – tension/anxiety and
confusion/bewilderment subscales improved for the
intervention condition at T2
 Program limited to
participants receiving
radiation Tx
 At post-assessment, 92%
(N=45) of intervention grp
still receiving radiation Tx at
4weeks, and 87% (N= 47) of
standard care grp still
receiving radiation Tx
 Cost of intervention was
$2000 per patient for eight
sessions
 Standard care could access
outside services
Clark et al.
(18) USA
 N=131 adults (inc. 22% BTs
[N=65 Intervention – inc.
n=11 BTs, N=66 standard
care – inc. n=18 BTs] with
advanced cancer, diagnosed
within last 12mths, with
intermediate to poor
prognosis and prescribed
radiation Tx (min. 1week)
 Mean age=59.3 yrs
 RCT with standard care
 Primary intervention:
– Structured multidisciplinary program
comprising 6  90 min sessions
followed by 10 brief structured
phone counseling sessions
– Session structure inc. 20min
physical exercises; education;
cognitive-behavioral strategies; open
discussion; support; and concluding
with 15min deep breathing and
guided imagery relaxation
– Content of program derived from
previous Rumman [10] study with
several modifications inc. caregiver
participation (Sessions 1, 3, 4, and
6); and focus on substance use,
mood, anxiety and sleep disorders
– Sessions led by clinical psychologist
or psychiatrist
– Participants issued with 200 page
manual
 Standard care condition:
– Received standard medical care
services
 Ax phases:
T1 – baseline
T2-Post-Tx/4weeks later (Primary
study end-point)
T3 – 27weeks from T1
 Primary outcome measures:
– QOL: Functional Assessment of
Cancer Therapy (FACT-G)
 Caregiver QOL: The Caregiver Quality
of Life Index – Cancer Scale
 Secondary outcome measures:
– Mood: Profile of Mood States (POMS)
– Functional Assessment of Chronic
Illness Therapy (FACIT) – Spiritual
well-being scale
– Sleep: Pittsburgh Sleep Quality Index
– Exercise behaviors
 T1–T2
 Complete data at primary endpoint (week 4
post-baseline) N=117 [N=54 intervention; N=63
standard care]; drop-outs due to no baseline and/or
T2 data (n=10); death (n=1), incomplete treatment
sessions (fout attended) (n=7)
– Greater QOL scores for intervention condition
(especially physical and functional wellbeing scores)
(intervention condition maintained scores – vs.
standard care condition decreased scores at T2)
 T1–T3 (5mths FU): (N=110; N=51 intervention,
N=59 Standard care)
– No sig. group differences, both conditions continued
to increase QOL scores (back to baseline/T1 levels)
 Secondary measures:
– All measures were not sig at both T2 and T3
 Caregiver QOL: No sig differences between
conditions
 Program limited to
participants receiving
radiation Tx
Ax, assessment; BT, brain tumor; grp, group; inc., includes/including; FU, follow-up; min, minimum; mths, months; ITT, intent-to treat; N, number of participants; QOL, quality-of-life; RCT, randomized control trial; sig., significant; T1,
assessment phase 1 (baseline); T2, assessment phase 2; T3, assessment phase 3; T4, assessment phase 4; Tx, treatment; yrs, years.
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well-being, relative to participants in standard care who reported
a decline in QOL scores. However, by 5-months follow-up, no
significant differences were evident between conditions. Notably,
both groups had returned to baseline functioning for QOL out-
comes. Additionally, no significant group differences emerged
at 4-week or 5-months follow-up for the secondary measures
including emotional and spiritual well-being, as well as sleep
functioning.
Discussion
For this scoping review, only four published RCT studies (15–18)
[one of which was a quasi-RCT design; (16)] were identi-
fied, which included adult BT patients in evaluating the effi-
cacy of psychosocial interventions designed to maintain and/or
improve QOL including existential well-being. Three of the stud-
ies (15, 17, 18) comprised structured, manualized multimodal
interventions, which included cognitive-behavioral strategies. The
fourth study (16) comprised a quasi-randomized design given the
final 3 patient dyads were directly allocated to the intervention
condition, which comprised a combined cognitive rehabilitation
and structured problem-solving therapy program.
In one of the only two published studies to date, which were
specifically designed for adults diagnosed with primary BTs,
Ownsworth et al. (15) found that the MSoBT program was found
to improve QOL and existential well-being, and reduce depressive
symptoms up to 6-months post-intervention. Given this is the
only published RCT study, which was designed for BT patients,
this reflects the notable paucity of psychosocial interventions
specifically tailored for adult BT patients. Although the findings
from this study are promising, there are several short-comings
that need to be considered in informing future interventions
in this field. First, only the initial, post-treatment results were
based on the RCT design, as the 6-month follow-up outcomes
included participants allocated to the wait-list condition. Sec-
ond, the intervention was not found to improve anxiety symp-
toms. Furthermore, although depressive symptoms were found
to improve post-intervention, this study was not specifically tai-
lored to clinically distressed (i.e., anxious and/or depressed) BT
patients.Hence, the effect of this intervention inmanaging anxiety
and depressive disorders in distressed BT patients is unknown.
Third, given the multimodal intervention, which also included
neuropsychological feedback and cognitive rehabilitation, it is
not clear which components contributed to specific treatment
gains. Finally, the home-based, in-person therapy sessions raise
feasibility issues for hospital and community settings, which
may not have the resources to roster staff to weekly offsite
home visits.
In the second study, whichwas specifically designed for patients
with a primary BT (as well as their carers) (16), a combined
cognitive rehabilitation and positive problem-solving interven-
tion was found to be acceptable by patients newly diagnosed with
BT undergoing radiation treatment, and who were assessed to
havemild tomoderate cognitive impairments. However, this com-
bined intervention was not found to lead to significant improve-
ments in terms of QOL, functional capacity, mood or fatigue
compared to patients who received standard medical care. These
null outcomes can most likely be attributed to the majority of
patients having good emotional adjustment and general well-
being at baseline (i.e., soon after their BT diagnosis), and which
was maintained at 3-months follow-up. In addition, given the
very small sample size (N= 19 dyads at baseline and N = 13
at the 3-month follow-up), Locke et al. acknowledge that their
study was not adequately powered to detect statistical changes.
Although the majority of patients who received the combined
intervention reported finding this program “somewhat” to “very”
helpful, the findings indicate that patients which are relatively
well adjusted emotionally may not derive further benefits in terms
of improvement of mood and QOL by receiving an intensive
cognitive and psychological short-term intervention while under-
going radiation treatment. Indeed, Locke et al. recommend that
for future research, targeting BT patients who report reduced
QOL, elevated emotional distress, and/or poor functional perfor-
mance may be fruitful to further test the feasibility of this type of
intervention.
The other two RCTs (17, 18) included in this review comprised
heterogeneous samples of adults diagnosed with advanced cancer
(including BT patients), who were recommended to receive radia-
tion treatment. BothRCTswere based on a comparable structured,
multidisciplinary psychosocial intervention, which also included
physical and relaxation exercises. Interestingly, both studies were
found to facilitate maintenance of QOL within 4weeks post-
baseline (on average 1-week post-intervention). However, the
intervention was not found to differ from standard care at
5-months follow-up. A potential explanation for this latter out-
come is that participants in standard care were documented to
have the opportunity to receive external support from agencies
such as the American Cancer Society [e.g., Ref. (17)]. However,
access to additional support services was not reported to be mon-
itored in these trials. It cannot therefore be ruled out that the
lack of group differences at 5-months follow-up may in part be
due to patients in the standard care condition accessing external
support. A further reason may also in part be due to the recovery
period required to overcome the acute radiation treatment side-
effects. In fact, at the 4-week assessment, more than 85% of the
sample was still receiving radiation treatment in the Rummans
et al. (17) study. Taken together, these findings suggest that this
multidisciplinary program is useful in helping patients maintain
theirQOLduring the course of their radiation treatment, although
there does not seem to be any additive benefits at 5-months follow-
up. This is further reflected in the non-significant results reported
for the secondary outcome measures. Notably, the intervention
was not found to lead to significant improvements in psycholog-
ical distress, mood, and spiritual well-being. Moreover, given the
heterogeneous sample composition, which comprised only a small
proportion of patients diagnosed with BTs (between 12 and 22%),
the findings from these two RCTs for patients with advanced BTs
are considered preliminary.
Collectively, the findings from this review accentuate the
paucity of studies that have been specifically designed for pri-
mary BT patients, and which have assessed the effects of psy-
chological interventions in managing anxiety and/or depressive
symptoms and/or improving QOL. Although a number of cog-
nitive rehabilitation programs for BT patients have also included
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measures of psychological distress and/or QOL [e.g., Ref. (23)],
however, with the exception of Locke et al.’s combined cognitive
and problem-solving intervention (16), no further published cog-
nitive rehabilitation studies were identified that also included
a psychological intervention. Moreover, as aforementioned, one
controlledMDRprogram for adult BTpatientswas identified (22),
and which did include access to psychological therapy. However,
no details were reported pertaining to what the therapy entailed,
and whether this was consistent across patients. Notwithstand-
ing this lack of detail, interestingly, this program was not found
to lead to significant improvements in anxiety, depressive, and
QOL scores for participants who completed the MDR program.
Comparable to Locke et al.’s findings (16), the null results from
the MDR programmay be due to patients not being clinically dis-
tressed at baseline, and hence, did not derive significant improve-
ment in emotional well-being by having access to psychotherapy.
Taken together, the findings from these two integrative cogni-
tive and psychological intervention programs attest to the need
to conjointly screen for both cognitive impairment and emo-
tional distress to ascertain which patients may benefit most from
multidisciplinary interventions which include a psychotherapy
component.
Importantly, given the high rates of psychological problems
experienced by BT patients [e.g., Ref. (1, 4)], it is surprising that no
published study to date was identified which was specifically tai-
lored to clinically distressed BT patients. Indeed, small tomedium
effects with mixed outcomes have emerged in the efficacy of
psychosocial interventions in managing emotional disturbances
in the broader (non-BT) oncology literature (24, 25). This may
in part be due to floor effects if patients are not experiencing
clinically elevated levels of distress at baseline. Indeed, in the
most recent and largest meta-analytic review of the effects of
psychosocial interventions tomanage emotional distress andQOL
in cancer patients, Faller et al. (24) found that only a very limited
number of studies preselected participants according to baseline
distress levels. Importantly, these studies showed the largest effect
sizes. In the current review, although Ownsworth et al. (15) found
a reduction in depressive symptoms, this was not comparably
found for anxiety symptoms. Moreover, the clinical diagnostic
status of patients at baseline was not reported.
Research has shown that depression and anxiety disorders
share common latent structures, which have contributed to a
recent increase in studies testing the concurrent treatment of
anxiety and mood disorders in the general population using
cognitive and behavioral based transdiagnostic therapies (26),
including the integration of behavioral strategies with acceptance-
based therapies [such as Acceptance and Commitment Therapy
(ACT)] (27, 28). Considering that anxiety problems have been
found to be associated with comorbid depressive symptoms in
adults diagnosed with a primary BT [e.g., Ref. (4, 7)], ACT-
based interventions may have particular relevance for distressed
BT patients given the objective of this approach is to improve
patients functionality and QOL in concordance with their values,
while also factoring in their shortcomings (19–30). Hence, for
adult BT patients, contingent on the extent of cognitive, sensory,
and physical deficits sustained due to the tumor and/or treatment
side-effects, patients can still re-learn how tomaintain an adaptive
QOL by engaging in value-based activities (e.g., enjoyment of
participating in team-based social events) they can partake in,
despite any impairment(s) they have sustained. Moreover, ACT
aligns with transdiagnostic approaches as the treatment compo-
nents are comparable for both managing anxiety and depressive
disturbances.
An ACT-Based Transdiagnostic Intervention for
BT Patients: A Pilot Case Study
Kangas et al. (31) developed a manualized ACT-based transdiag-
nostic intervention (which includedpatient handouts, worksheets,
and a CD) with the aim of improving the emotional well-being
and QOL of distressed adults with primary BTs. In line with ACT
principles, the program comprised the following components
which targeted: (1) education about common reactions to being
diagnosed with a BT; (2) acceptance, defusion, and mindfulness
based exercises to promote awareness and acceptance of internal
physical sensations and cognitions; (3) learning to deal with the
uncertainty of a BT diagnosis and prognosis by using acceptance
and mindfulness strategies; (4) behavioral exercises to re-engage
in avoided activities; and (5) re-evaluating life-goals concordant
with one’s values in at least three key domains – interpersonal,
personal/self-care, and occupational, in order to engage or re-
engage and commit to pursuing valued life goals. This program
was designed to be conducted in-person over 6-weekly, 90min
sessions, including two additional “booster” sessions to consoli-
date skills learnt, scheduled at fortnightly intervals.
Kangas et al. (31) initially pilot tested the ACT intervention
with a middle-aged male, “Luke” (aged 53 years), diagnosed with
ameningioma 2.3 years prior and had completed his BT treatment
(including a craniotomy and 20 sessions of fractionated stereotac-
tic radiotherapy) 18months prior to referral to the program. Luke
completed a comprehensive assessment including a diagnostic
clinical interview, self-report measures, and neuropsychological
testing at four phases: baseline (T1), end of therapy (T2), 1-month
(T3), and 3-months (T4), following completion of the 8-session
program. At baseline, Luke met comorbid criteria for both Major
Depressive Disorder and anxiety (including Generalized Anxiety
Disorder and BT-related PTSD). His QOL scores on the Func-
tional Assessment of Cancer Therapy – General and Brain sub-
scale (FACT-G/BR) (32) were very low, >3 SDs below published
norms. He also reported low acceptance and high experiential
avoidance of negative cognitions and physiological bodily sen-
sations since his BT diagnosis, as assessed by the Acceptance
of Actions Questionnaire (AAQ) (33). This scale measures an
individual’s avoidance of negative perceived cognitions (including
thoughts, beliefs, and perceptions) and physical sensations. His
memory and cognitive skills were assessed to be in the average
to above average range, although his problem-solving scores were
slightly below average. By the end of therapy, Luke no longer met
criteria for depression or anxiety. With a reduction in depressive
symptoms [as measured by the Beck Depression Inventory – 2nd
Edition; (34)], and a decline in experiential avoidance, Luke also
increased his problem-solving skills and QOL. In particular, he
engaged in substantially more social events and reintegrated with
his social network. These effects were maintained at 3-months
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follow-up. These case report findings demonstrate that this ACT-
based intervention has potential, promising utility in treating
both anxiety and depression disturbances in distressed adults
diagnosed and treated for a primary BT. However, the efficacy of
this program needs to be tested in future research using a large
scale controlled trial design, particularly as there is a dearth of
studies that have been specifically tailored for distressed adult BT
survivors.
It is acknowledged that this scoping review was limited to
published studies in the English language. Also, the abstracts
and extracted data were not independently evaluated by a second
reviewer. Notwithstanding these limitations, a more integrative
scoping reviewmethodwas used to keep the study aim specifically
focused on identifying psychological interventions for adult BT
patients which anxiety, depression, and/or QOL indices were
included as outcome measures in evaluating the effects of the
intervention. Moreover, in accord with recent recommendations
for scoping reviews (9), the methodology of identified studies
was critically evaluated in line with relevant components of the
PRISMA (14) framework in order to clearly delineate gaps in this
field and guide future research trials.
Conclusion
In conclusion, the findings from this scoping review demonstrate
that there is a notable paucity of published controlled trials which
have tested the efficacy of any type of psychological based inter-
vention in managing the emotional wellbeing (notably, anxiety
and/or depressive symptoms) and QOL of adults diagnosed with
a primary BT across the illness trajectory. To date, the outcome
from Ownsworth et al.’s (15) RCT study accentuates the potential
utility in using a multimodal approach including cognitive and
behavioral strategies to enhance theQOLand existential wellbeing
of BT survivors. In order to strengthen the evidence base in this
field, future research is pressinglywarranted to further test the effi-
cacy of psychological interventions inmanaging emotional distur-
bances and maintaining and/or improving the QOL, particularly
in clinically distressed BT patients and longer-term survivors.
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